DNAM‐1 control of natural killer cells functions through nectin and nectin‐like proteins

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Immunology and Cell Biology

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/icb.2013.95PMID 24343663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway.

  2013cited by this paper
• ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

  2013cited by this paper
• Molecular mechanisms of natural killer cell activation in response to cellular stress

  2013cited by this paper
• CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis.

  2013cited by this paper
• Controlling natural killer cell responses: integration of signals for activation and inhibition.

  2013cited by this paper
• Mouse TIGIT inhibits NK‐cell cytotoxicity upon interaction with PVR

  2013cited by this paper
• Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2

  2013cited by this paper
• Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells

  2013cited by this paper
• NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses

  2013cited by this paper
• The CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in Humans

  2013cited by this paper
• CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection.

  2012cited by this paper
• Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells

  2012cited by this paper
• The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR

  2012cited by this paper
• Cell Function The TIGIT/CD226 Axis Regulates Human T

  2012cited by this paper
• Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patients

  2012cited by this paper
• Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis

  2012cited by this paper
• The TIGIT/CD226 Axis Regulates Human T Cell Function

  2012cited by this paper
• Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.

  2012cited by this paper
• The TIGIT / CD 226 Axis Regulates Human

  2012cited by this paper
• Complementary Phosphorylation Sites in the Adaptor Protein SLP-76 Promote Synergistic Activation of Natural Killer Cells

  2012cited by this paper
• Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

  2011cited by this paper
• Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.

  2011cited by this paper
• Vstm3 is a member of the CD28 family and an important modulator of T‐cell function

  2011cited by this paper
• Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions

  2011cited by this paper
• Intranodal Interaction with Dendritic Cells Dynamically Regulates Surface Expression of the Co-stimulatory Receptor CD226 Protein on Murine T Cells*

  2011cited by this paper
• Mobilization of natural killer cells inhibits development of collagen-induced arthritis

  2011cited by this paper
• NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

  2011cited by this paper
• Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

  2011cited by this paper
• DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.

  2011cited by this paper
• Association of the CD226 single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han population.

  2011cited by this paper
• Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112

  2010cited by this paper
• Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

  2010cited by this paper
• NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.

  2010cited by this paper
• Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.

  2010cited by this paper
• Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases.

  2010cited by this paper
• Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infection

  2010cited by this paper
• Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients

  2009cited by this paper
• DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

  2009cited by this paper
• A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC

  2009cited by this paper
• The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

  2009cited by this paper
• Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation1

  2009cited by this paper
• ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.

  2009cited by this paper
• Natural killer cells in human autoimmunity.

  2009cited by this paper
• CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains*

  2009cited by this paper
• The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

  2009cited by this paper
• NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

  2009cited by this paper
• Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells1

  2009cited by this paper
• NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.

  2008cited by this paper
• Up on the tightrope: natural killer cell activation and inhibition

  2008cited by this paper
• Immunological aspects of cancer chemotherapy

  2008cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Accelerated tumor growth in mice deficient in DNAM-1 receptor

  2008cited by this paper
• DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

  2008cited by this paper
• Natural killer cell recognition of missing self

  2008cited by this paper
• Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.

  2008cited by this paper
• Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

  2007cited by this paper
• The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

  2007cited by this paper
• Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

  2007cited by this paper
• The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1.

  2007cited by this paper
• Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.

  2006cited by this paper
• Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

  2006cited by this paper
• Reciprocal regulation between natural killer cells and autoreactive T cells

  2006cited by this paper
• The DNA damage response arouses the immune system.

  2006cited by this paper
• Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141

  2005cited by this paper
• CD226 Is Specifically Expressed on the Surface of Th1 Cells and Regulates Their Expansion and Effector Functions1

  2005cited by this paper
• Cutting Edge: CD96 (Tactile) Promotes NK Cell-Target Cell Adhesion by Interacting with the Poliovirus Receptor (CD155)

  2004cited by this paper
• The LFA-1-associated Molecule PTA-1 (CD226) on T Cells Forms a Dynamic Molecular Complex with Protein 4.1G and Human Discs Large*

  2004cited by this paper
• Biology and pathology of nectins and nectin-like molecules.

  2004cited by this paper
• Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

  2004cited by this paper
• Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells

  2004cited by this paper
• Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

  2004cited by this paper
• Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

  2003cited by this paper
• The MAGUK family protein CARD11 is essential for lymphocyte activation.

  2003cited by this paper
• CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation

  2003cited by this paper
• Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

  2003cited by this paper
• Identification of PVR ( CD 155 ) and Nectin-2 ( CD 112 ) as Cell Surface Ligands for the Human DNAM-1 ( CD 226 ) Activating Molecule

  2003cited by this paper
• CD 226 ( DNAM-1 ) Is Involved in Lymphocyte Function – associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation

  2003cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• The expanding world of co-stimulation: the two-signal model revisited.

  2001cited by this paper
• NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

  2001cited by this paper
• CARD11 and CARD14 Are Novel Caspase Recruitment Domain (CARD)/Membrane-associated Guanylate Kinase (MAGUK) Family Members that Interact with BCL10 and Activate NF-κB*

  2001cited by this paper
• GAKIN, a Novel Kinesin-like Protein Associates with the Human Homologue of the Drosophila Discs Large Tumor Suppressor in T Lymphocytes*

  2000cited by this paper
• Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity.

  1999cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Physical and functional association of LFA-1 with DNAM-1 adhesion molecule.

  1999cited by this paper
• Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis.

  1998cited by this paper
• Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor.

  1998cited by this paper
• Role of natural killer cells and TCRγ δ T cells in acute autoimmune encephalomyelitis

  1998cited by this paper
• A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.

  1998cited by this paper
• Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells

  1997cited by this paper
• DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.

  1996cited by this paper
• Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily.

  1992cited by this paper
• Characterization of a novel membrane glycoprotein involved in platelet activation.

  1989cited by this paper
• TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors

  1985cited by this paper
• Immunological Aspects of Cancer Chemotherapy

  1980cited by this paper
• The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine

  year unknowncited by this paper

• Immunotherapeutic strategies targeting the PVR–TIGIT/CD96/CD226 signaling pathway in glioma treatment

  2025cites this paper
• Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment

  2025influential citation
• Multidimensional plasticity of natural killer cells in tumours

  2025cites this paper
• Negative Immune Checkpoint Inhibitors

  2025cites this paper
• Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies.

  2025cites this paper
• The Immune Regulatory Functions of CD226 and Its Implications in Immune-Mediated Diseases

  2025cites this paper
• CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma

  2025cites this paper
• The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies

  2025cites this paper
• Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation

  2025cites this paper
• Immune checkpoints in immune response to glioma: two sides of the same coin

  2025cites this paper
• Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling

  2024cites this paper
• Pan-cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers

  2024cites this paper
• Genetic Variant of DNAM-1 rs763361 C>T Is Associated with Ankylosing Spondylitis in a Mexican Population

  2024cites this paper
• A review and statistical analysis to identify and describe relationships between CQAs and CPPs of natural killer cell expansion processes.

  2024cites this paper
• Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis

  2024cites this paper
• CD155 and Its Receptors as Targets for Cancer Therapy

  2023cites this paper
• CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy.

  2023cites this paper
• SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses

  2023cites this paper
• CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma

  2023cites this paper
• AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation

  2023cites this paper
• Clinical significance of serum CD155 levels in acute lymphoblastic leukemia patients

  2023cites this paper
• Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals

  2023cites this paper
• Uncoupling of Natural Killer cell functional maturation and cytolytic function in NOD mice

  2023cites this paper
• Killer instincts: natural killer cells as multifactorial cancer immunotherapy

  2023cites this paper
• OMIP‐099: 31‐color spectral flow cytometry panel to investigate the steady‐state phenotype of human T cells

  2023cites this paper
• Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review

  2023cites this paper
• CD155 in tumor progression and targeted therapy.

  2022cites this paper
• Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery

  2022cites this paper
• IRF2 is required for development and functional maturation of human NK cells

  2022cites this paper
• Designing Cancer Immunotherapies That Engage T Cells and NK Cells.

  2022cites this paper
• Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis

  2022cites this paper
• Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells

  2022cites this paper
• Emergence of the CD226 Axis in Cancer Immunotherapy

  2022cites this paper
• Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes

  2022cites this paper
• Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and Challenges.

  2022cites this paper
• Genome-Wide Association Study Demonstrates the Role Played by the CD226 Gene in Rasa Aragonesa Sheep Reproductive Seasonality

  2021cites this paper
• Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

  2021cites this paper
• Insights Into Human Intrahepatic NK Cell Function From Single Cell RNA Sequencing Datasets

  2021cites this paper
• Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors

  2021cites this paper
• Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis

  2021cites this paper
• Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape

  2021cites this paper
• Aging of Natural Killer Cells in Acute Myeloid Leukemia

  2020cites this paper
• Natural Killer Cells: Tumor Surveillance and Signaling

  2020cites this paper
• Natural Killer Cells as Sensors of Adipose Tissue Stress.

  2020cites this paper
• Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance

  2020cites this paper
• Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation

  2020cites this paper
• Control of Viral Infection by Natural Killer Cell Inhibitory Receptors

  2020cites this paper
• CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

  2020cites this paper
• Targeting CD155 on Myeloid Derived Suppressor Cells to Prevent Postoperative Immunosuppression in Cancer Patients

  2020cites this paper
• CD155: A Multi-Functional Molecule in Tumor Progression

  2020cites this paper
• Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions.

  2019cites this paper
• Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor

  2019cites this paper
• The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control

  2019cites this paper
• Age-Associated Alterations on Natural Killer Cells in Acute Myeloid Leukemia Patients

  2019cites this paper
• PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function

  2019cites this paper
• Interaction between nectin-1 and the human natural killer cell receptor CD96

  2019cites this paper
• Single‐Use Bioreactors for Manufacturing of Immune Cell Therapeutics

  2019cites this paper
• Co-signaling Molecules in Neurological Diseases.

  2019cites this paper
• NK cell-based therapeutics for lung cancer

  2019cites this paper
• Migrant or resident? The identification of group 1 innate lymphoid cells in the murine central nervous system

  2019cites this paper
• Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention

  2019cites this paper
• DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?

  2019cites this paper
• Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy

  2019cites this paper
• DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy

  2019cites this paper
• Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy

  2019cites this paper
• Characteristics of NK cells from leukemic microenvironment in MLL‐AF9 induced acute myeloid leukemia

  2018cites this paper
• CMV and natural killer cells: shaping the response to vaccination

  2018cites this paper
• Targeting PVR (CD155) and its receptors in anti-tumor therapy

  2018cites this paper
• Loss of Canonical Notch Signaling Affects Multiple Steps in NK Cell Development in Mice

  2018cites this paper
• CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes

  2018cites this paper
• Interactions between tumour and natural killer cells in primary and secondary liver cancer

  2018cites this paper
• Chapter 3 NK Cells in Cancer Immunotherapy

  2018cites this paper
• NK cell therapy for hematologic malignancies

  2018cites this paper
• CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

  2018cites this paper
• NK Cells in Cancer Immunotherapy

  2017cites this paper
• In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients

  2017cites this paper
• CD8+T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients.

  2017cites this paper
• Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib

  2017cites this paper
• Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.

  2017cites this paper
• Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment

  2017cites this paper
• Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges

  2017cites this paper
• Role of ion channels in natural killer cell function towards cancer.

  2017cites this paper
• Immune modulation in serous epithelial ovarian cancer

  2017cites this paper
• High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults

  2017cites this paper
• Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

  2017cites this paper
• Innate immune cells for immunotherapy of autoimmune and cancer disorders

  2017cites this paper
• Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines

  2017cites this paper
• Bench to bedside: NK cells and control of metastasis.

  2017cites this paper
• The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

  2017cites this paper
• Immune responses against tumors controlled by the actin cytoskeleton : lessons from primary immunodeficiencies

  2017cites this paper
• Ubiquitin and ubiquitin-like modifiers modulate NK cell-mediated recognition and killing of damaged cells

  2017cites this paper
• Immune modulation in serous epithelial ovarian cancer : focus on the role of tumor-derived exosomes

  2017cites this paper
• Roles for NK Cells and ILC1 in Inflammation and Infection

  2017cites this paper
• The regulation of NK cell detachment from target cells as a key factor for serial killing and effector function

  2017cites this paper
• ANTICORPS ANTI-TIGIT, ANTICORPS ANTI-PVRIG ET COMBINAISONS ASSOCIÉES

  2017cites this paper
• Poliovirus Receptor: More than a simple viral receptor.

  2017cites this paper
• Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer

  2016cites this paper
• Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression

  2016cites this paper
• Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?

  2016cites this paper
• Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155

  2016cites this paper